STOCK TITAN

Insider linked to RMD (NYSE: RMD) plans sale of 1,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Brett Sandercock filed a notice of proposed sale of 1,000 shares of common stock with an aggregate market value of 257,030.00, to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026.

The 1,000 shares were acquired on 11/11/2022 through restricted stock vesting from the issuer as compensation. Over the prior three months, Brett Sandercock sold 3,000 common shares on 11/03/2025 for gross proceeds of 742,620.00, 1,000 shares on 12/01/2025 for 244,160.00, and 1,000 shares on 01/02/2026 for 241,750.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 filing related to RMD disclose?

The notice discloses a planned sale of 1,000 common shares with an aggregate market value of 257,030.00 through Fidelity Brokerage Services LLC on the NYSE, with the seller identified as Brett Sandercock and the approximate sale date of 02/02/2026.

How many RMD shares is Brett Sandercock proposing to sell under this Form 144?

Brett Sandercock proposes to sell 1,000 common shares. The filing lists these shares with an aggregate market value of 257,030.00, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/02/2026.

How and when were the 1,000 RMD shares being sold originally acquired?

The 1,000 shares were acquired on 11/11/2022 via restricted stock vesting from the issuer. The filing classifies the acquisition’s nature as compensation, with the same date listed as the payment date and the amount of securities acquired shown as 1,000 shares.

What RMD share sales has Brett Sandercock made in the past three months?

The filing lists three sales: 3,000 common shares on 11/03/2025 for gross proceeds of 742,620.00, 1,000 shares on 12/01/2025 for 244,160.00, and 1,000 shares on 01/02/2026 for 241,750.00, all attributed to Brett Sandercock.

On which exchange are the RMD shares in this Form 144 planned to be sold?

The proposed sale is listed for the NYSE. The filing specifies that 1,000 common shares with an aggregate market value of 257,030.00 are to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026.

Who is the broker named in the RMD-related Form 144 filing?

The broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing associates this broker with the planned sale of 1,000 common shares valued in aggregate at 257,030.00 on the NYSE.
Resmed

NYSE:RMD

RMD Rankings

RMD Latest News

RMD Latest SEC Filings

RMD Stock Data

37.63B
145.22M
0.79%
64.76%
5.81%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO